Novel benzoxaborole, nitroimidazole and aminopyrazoles with activity against experimental cutaneous leishmaniasis

OBJECTIVES: Drugs for Neglected Diseases initiative (DNDi) has identified three chemical lead series, the nitroimidazoles, benzoxaboroles and aminopyrazoles, as innovative treatments for visceral leishmaniasis. The leads discovered using phenotypic screening, were optimised following disease- and co...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Parasitol Drugs Drug Resist
Autors principals: Van Bocxlaer, Katrien, Caridha, Diana, Black, Chad, Vesely, Brian, Leed, Susan, Sciotti, Richard J., Wijnant, Gert-Jan, Yardley, Vanessa, Braillard, Stéphanie, Mowbray, Charles E., Ioset, Jean-Robert, Croft, Simon L.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2019
Matèries:
Includes articles from the special issue “Novel therapies for cutaneous leishmaniasis”, pp. 106 - 179
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6904836/
https://ncbi.nlm.nih.gov/pubmed/30922847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpddr.2019.02.002
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars